Clinical significance of indoleamine 2,3-dioxygenase expression in human acute leukemia
10.3760/cma.j.issn.1009-9921.2015.02.011
- VernacularTitle:吲哚胺2,3双加氧酶在急性白血病细胞的表达及其临床意义
- Author:
Xiangli CHEN
;
Jianmin GUO
;
Yin ZHANG
;
Xiaona NIU
;
Xiaohang PEI
;
Wenhui ZHANG
- Publication Type:Journal Article
- Keywords:
Leukemia,acute;
Indoleamine 2,3-dioxygenase;
Prognosis
- From:
Journal of Leukemia & Lymphoma
2015;24(2):111-114
- CountryChina
- Language:Chinese
-
Abstract:
Objective To determine the expression of indole-2,3 dioxygenase (IDO) in human acute leukemia,and to investigate its correlations with clinicopathological parameters and prognosis in acute leukemia.Methods The expression of IDO in protein and RNA levels was detected by immunohistochemistry and real-time quantitative RT-PCR,respectively,and the correlations of IDO with clinicopathologic features and prognosis of acute myeloid leukemia (AML)-M5 were analyzed.Results The positive rate of IDO protein was 63.3 ％ (38/60) in human acute leukemia,while it in AML (34/49,69.4 ％),especially in AML-M5 patients (29/35,82.9 ％),was significantly higher than that of acute lymphoblastic leukemia (4/11,36.4 ％).The expression of IDO protein in healthy human peripheral blood mononuclear cells was negative.The RNA expression level of IDO in AML-M5 or non AML-M5 patients were significantly higher than that of healthy people (P ＜ 0.001),and AML-M5 patients had significantly higher IDO RNA level than that in non AML-M5 patients (P ＜ 0.05).The IDO gene expression was not correlated with sex,age and drug sensitivity,while it was closely related with these factors in the patients without complication of pulmonary infection.IDO could not act as an independent prognostic marker.Conclusion The expression of IDO in AML-M5 patients is significantly higher than that in non AML-M5 patients and healthy people.The positive expression of IDO is associated with poor prognosis of AML-M5 patients,but it is not an independent poor prognostic indicator.
